Cellectar Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q2 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q3 2024 | 2 | -$0.41 | -$0.25 | -$0.33 |
| Q4 2024 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q1 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q1 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2026 | 1 | $0.03 | $0.03 | $0.03 |
Cellectar Biosciences, Inc. Earnings Date And Information
Cellectar Biosciences, Inc. last posted its earnings results on Monday, November 11th, 2024. The company reported $-0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-0.34 by $0.31. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cellectar Biosciences, Inc. has generated $-3 earnings per share over the last year ($-3.11 diluted earnings per share) and currently has a price-to-earnings ratio of -1.45. Cellectar Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
Cellectar Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q2 2024 | -$0.19 | $0 | $0 | ||
| 10/29/2024 | Q1 2024 | -$0.74 | $0 | $0 | ||
| 04/01/2024 | Q4 2023 | -$0.40 | $330,366 | |||
| 11/13/2023 | Q3 2023 | -$0.44 | -$1.21 | -0.77 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.69 | -$0.73 | -0.04 | $0 | |
| 05/04/2023 | Q1 2023 | -$0.75 | -$0.75 | 0 | $0 | |
| 03/09/2023 | Q4 2022 | -$0.83 | -$0.77 | 0.06 | $0 | |
| 11/03/2022 | Q3 2022 | -$1.21 | -$1.28 | -0.07 | $0 | |
| 08/05/2022 | Q2 2022 | -$1.08 | -$1.22 | -0.14 | $0 | |
| 05/10/2022 | Q1 2022 | -$1.10 | -$1.00 | 0.1 | $0 | |
| 03/21/2022 | Q4 2021 | -$1.00 | -$0.99 | 0.01 | $0 | |
| 11/08/2021 | Q3 2021 | -$1.10 | -$0.97 | 0.13 | $0 | |
| 08/09/2021 | Q2 2021 | -$1.10 | -$1.14 | -0.04 | $0 | |
| 05/10/2021 | Q1 2021 | -$0.90 | -$1.32 | -0.42 | $0 | |
| 04/30/2021 | Q4 2020 | -$2.62 | $0 | |||
| 11/09/2020 | Q3 2020 | -$1.50 | -$1.49 | 0.01 | $0 | |
| 08/10/2020 | Q2 2020 | -$3.00 | -$2.62 | 0.38 | $0 | |
| 05/07/2020 | Q1 2020 | -$3.40 | -$4.21 | -0.81 | $0 | |
| 03/09/2020 | Q4 2019 | -$3.60 | -$3.60 | 0 | $0 | |
| 11/12/2019 | Q3 2019 | -$3.80 | -$4.16 | -0.36 | $0 |
Cellectar Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Cellectar Biosciences, Inc.'s earnings date?
Cellectar Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
-
Did Cellectar Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cellectar Biosciences, Inc. (:CLRB) reported $-0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.31.
-
How can I listen to Cellectar Biosciences, Inc.'s earnings conference call?
The conference call for Cellectar Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Cellectar Biosciences, Inc.'s conference call transcript?
The conference call transcript for Cellectar Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Cellectar Biosciences, Inc. generate each year?
Cellectar Biosciences, Inc. (:CLRB) has a recorded net income of $0. Cellectar Biosciences, Inc. has generated $-3.11 earnings per share over the last four quarters.
-
What is Cellectar Biosciences, Inc.'s price-to-earnings ratio?
Cellectar Biosciences, Inc. (:CLRB) has a price-to-earnings ratio of -1.45 and price/earnings-to-growth ratio is -0.06.
